For patients suffering from irreparable laryngeal damage or laryngeal cancer, a total laryngectomy is often the only option1. Total laryngectomy leaves patients without the ability to breathe and speak on their own, in addition to experiencing social and psychological distress2. Patients with laryngeal cancer who need a total laryngectomy are excellent potential candidates for laryngeal transplantation. While human laryngeal transplantation in the setting of irreparable laryngeal damage has been performed, allotransplantation of the larynx is currently avoided in these patients due to the fear of tumor recurrence, the possibility of chronic rejection, and donor-derived infections3. Immunosuppression is the primary cause of these concerns. The dramatic loss of the first partial laryngeal transplant patient due to tumor recurrence after conventional immunosuppressive treatment is evidence that an appropriate immunosuppressive regimen should be devised before further attempts are made for transplantation in laryngeal cancer patients4,5.
To better understand the host immune response to a transplanted larynx, the first laryngeal transplant model in rats was developed in 1992 by Strome, and improvements to the surgical technique were made in 20026,7. Although this model is effective for studying laryngeal transplantation, the lack of rat-specific immunological agents and the higher cost associated with rat models led to the development of a new mouse model for studying laryngeal transplantation in 20098.
The main application of the described technique is to study different immunosuppressive drug regimens in laryngeal transplantation. Improving current immunosuppressive therapies may broaden the candidate pool and lead to safe transplantation in cancer patients. The benefits of this mouse model are its cost-effectiveness and the wide availability of immunologic data and reagents.
Teams working on immunosuppressive treatment regimens for laryngeal transplantation can use this method to collect a large volume of immunologic data, and different drug regimens can be rapidly tested and compared. Other potential treatment modalities that can modulate the immune response to the transplant, such as stem cell injections, can also be tested using this model. Finally, experiments can be devised to observe long-term systemic effects of laryngeal transplantation by extending the follow-up period.
The technique described here uses end-to-side anastomoses to provide arterial and venous flow to a heterotopic larynx graft. The graft is a laryngotracheoesophageal (LTE) complex comprising the larynx, thyroid glands, parathyroid glands, trachea, and esophagus of the donor, with bilateral carotid arteries and pedicles intact. One donor carotid artery is anastomosed to the recipient carotid artery and provides arterial blood flow, while the other donor carotid artery is anastomosed to the recipient external jugular vein and provides venous blood flow (Figure 1).
Several modifications were made to the surgical technique of the rat model to ensure success in the mouse model. For instance, an inhaled anesthetic agent was used instead of an injectable agent to increase control over the depth of anesthesia and reduce complications. Continuous suturing is used in the arterial-arterial anastomosis in rats; however, due to the smaller size of mouse vessels, this is technically difficult and can cause narrowing of the vessel lumen7. As a result, interrupted sutures are used in the mouse model and result in improved vessel patency. Additionally, in the rat model, the superior thyroid artery (STA) pedicle is dissected out and visualized. Given the smaller size of the STA in mice, this dissection could result in damage to and even transection of the STA. As a result, it is not dissected in the mouse model. Instead, nearby fascia is preserved to ensure that the STA is kept intact.
The major potential pitfalls of this technique include damaging the donor LTE complex pedicles, making an incorrectly sized arteriotomy or venotomy, vessel occlusion at the anastomosis sites, or leaving gaps at the anastomosis sites which may cause bleeding. To avoid these missteps, care must be taken when procuring the donor graft by leaving a cuff of tissue around the STA pedicle. The arteriotomy and venotomy should be large enough to allow blood flow but small enough to prevent leakage. An appropriate number of sutures should be used for the anastomoses to close any gaps, but not too many to occlude the vessels.
If familiarity with the microsurgical techniques is obtained, this procedure can be performed in approximately 3 h. This laryngeal transplantation model can be performed reliably in mice and used to study the host immune response after vascularized composite allotransplantation.